![]() Design Therapeutics Design Therapeutics is a biotechnology company that develops therapies for serious degenerative disorders caused by nucleotide repeat expansions. | Cells for Cells Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies. | ![]() Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. | ![]() Escient Pharmaceuticals Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. | |
Founding Date | Founding Date 2017 | Founding Date 2010 | Founding Date 2002 | Founding Date N/A |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Carlsbad, US HQ New York, US San Diego, US San Diego, US | Locations Las Condes, CL HQ | Locations Stockholm, SE HQ Leiden, NL | Locations San Diego, US HQ |
Employees | Employees 22 | Employees 28 | Employees 29 | Employees 39 |
Valuation ($) | Valuation ($) 634.6 m | Valuation ($) N/A | Valuation ($) 47.1 m | Valuation ($) N/A |
Alexa Website Rank | Alexa Website Rank 358868 | Alexa Website Rank 93355 | Alexa Website Rank 546679 | Alexa Website Rank 136663 |
Employee Rating | Employee Rating N/A | Employee Rating 3 | Employee Rating N/A | Employee Rating N/A |
Funding | ||||
Total funding raised | Total funding raised $ 45m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 117.5m |
Cells for Cells is a biotechnology company dedicated to the research, development, and commercialization of cellular therapies.
View companyImmunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
View companyEscient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.
View company